Back in July, we told you about a landmark cardiovascular outcomes study with lorcaserin. We only had topline results at that point, but we knew that this would be big. Today, we have a publication in the New England Journal of Medicine, an editorial, and lots of hyperbolic buzz in headlines all over the world. […]

